SEC24B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.707400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.229200E-01
Normal-vs-Stage2
9.574200E-01
Normal-vs-Stage3
1.821570E-01
Normal-vs-Stage4
4.264800E-01
Stage1-vs-Stage2
8.921800E-01
Stage1-vs-Stage3
1.570800E-01
Stage1-vs-Stage4
3.425200E-01
Stage2-vs-Stage3
2.283000E-01
Stage2-vs-Stage4
9.373600E-02
Stage3-vs-Stage4
1.292590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.464400E-01
Normal-vs-AfricanAmerican
6.484000E-01
Normal-vs-Asian
4.990600E-01
Caucasian-vs-AfricanAmerican
3.055600E-01
Caucasian-vs-Asian
2.032800E-01
AfricanAmerican-vs-Asian
1.737230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.197200E-01
Normal-vs-Female
9.671000E-01
Male-vs-Female
5.788600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.523000E-01
Normal-vs-Age(41-60Yrs)
5.805200E-01
Normal-vs-Age(61-80Yrs)
7.361000E-01
Normal-vs-Age(81-100Yrs)
5.673400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.796400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.635600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.593400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.295030E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.332300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.737200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.323000E-01
Normal-vs-Daily Drinker
4.345600E-01
Normal-vs-Weekly Drinker
7.391200E-01
Normal-vs-Occasional Drinker
6.429800E-01
Normal-vs-Social Drinker
7.239000E-01
Non Drinker-vs-Daily Drinker
5.073200E-01
Non Drinker-vs-Weekly Drinker
9.507000E-01
Non Drinker-vs-Occasional Drinker
5.976500E-02
Non Drinker-vs-Social Drinker
1.155180E-01
Daily Drinker-vs-Weekly Drinker
5.857600E-01
Daily Drinker-vs-Occasional Drinker
2.578300E-02
Daily Drinker-vs-Social Drinker
5.484400E-02
Weekly Drinker-vs-Occasional Drinker
1.839550E-01
Weekly Drinker-vs-Social Drinker
2.693800E-01
Occasional Drinker-vs-Social Drinker
8.837000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.738200E-02
Normal-vs-Grade 2
4.819700E-03
Normal-vs-Grade 3
6.283300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.220400E-01
Grade 1-vs-Grade 3
1.459390E-01
Grade 1-vs-Grade 4
6.738200E-02
Grade 2-vs-Grade 3
1.911160E-01
Grade 2-vs-Grade 4
4.819700E-03
Grade 3-vs-Grade 4
6.283300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.437200E-01
Normal-vs-NonDiabetic
9.280200E-01
Diabetic-vs-NonDiabetic
4.523600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.996400E-01
Normal-vs-NoPancreatitis
9.101200E-01
Pancreatitis-vs-NoPancreatitis
9.953800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.933000E-01
Normal-vs-N1
9.917400E-01
N0-vs-N1
9.998600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.440200E-01
Normal-vs-TP53-NonMutant
9.447800E-01
TP53-Mutant-vs-TP53-NonMutant
3.986600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
